PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.70%
Net income growth under 50% of MCHP's 56.01%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-1.75%
Negative yoy D&A while MCHP is 1.30%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-285.71%
Negative yoy deferred tax while MCHP stands at 685.66%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-4.08%
Both cut yoy SBC, with MCHP at -6.98%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
148.85%
Slight usage while MCHP is negative at -145.34%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
84.57%
AR growth well above MCHP's 17.37%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
9.59%
Some inventory rise while MCHP is negative at -171.72%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
100.00%
A yoy AP increase while MCHP is negative at -94.65%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
8100.00%
Some yoy usage while MCHP is negative at -97.05%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
No Data
No Data available this quarter, please select a different quarter.
134.52%
Some CFO growth while MCHP is negative at -21.17%. John Neff would note a short-term liquidity lead over the competitor.
-39.93%
Both yoy lines negative, with MCHP at -212.58%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
1.63%
Some yoy expansion while MCHP is negative at -80.44%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-64.00%
We reduce yoy sales while MCHP is 73.82%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-424.51%
Both yoy lines negative, with MCHP at -106.37%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-18.00%
Negative yoy issuance while MCHP is 13.90%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
20.00%
Buyback growth of 20.00% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.